Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven W Martin

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Pharmacokinetics and Pharmacodynamics|July 18, 2008
Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal womenMatthew L Zierhut, Marc R Gastonguay, Steven W Martin, et al.
Gut|February 15, 2011
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised studySéverine Vermeire, Subrata Ghosh, Julian Panes, et al.
Drugs in R&D|September 11, 2020
Comparability Considerations and Challenges for Expedited Development Programs for Biological ProductsSarah J Schrieber, Wendy S Putnam, Edwin Chiu Yuen Chow, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2004
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal womenPirow J Bekker, Donna L Holloway, Amy S Rasmussen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2011
How current understanding of clearance mechanisms and pharmacodynamics of therapeutic proteins can be applied for evaluation of their drug-drug interaction potentialEugenia Kraynov, Steven W Martin, Susan Hurst, et al.
The AAPS Journal|June 2, 2011
AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical developmentSandhya Girish, Steven W Martin, Mark C Peterson, et al.
Cancer|January 28, 2003
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastasesJean-Jacques Body, Philip Greipp, Robert E Coleman, et al.
Inflammatory Bowel Diseases|August 24, 2021
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II StudyGeert R D'Haens, Walter Reinisch, Scott D Lee, et al.
Journal of Crohn'S & Colitis|September 30, 2017
Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn's DiseaseMina Hassan-Zahraee, Anindita Banerjee, John B Cheng, et al.
Journal of Medicinal Chemistry|March 25, 2010
Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humansMark I Lansdell, David Hepworth, Andrew Calabrese, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Pharmacokinetics and Pharmacodynamics|July 18, 2008
Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal womenMatthew L Zierhut, Marc R Gastonguay, Steven W Martin, et al.
Gut|February 15, 2011
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised studySéverine Vermeire, Subrata Ghosh, Julian Panes, et al.
Drugs in R&D|September 11, 2020
Comparability Considerations and Challenges for Expedited Development Programs for Biological ProductsSarah J Schrieber, Wendy S Putnam, Edwin Chiu Yuen Chow, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 5, 2004
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal womenPirow J Bekker, Donna L Holloway, Amy S Rasmussen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 20, 2011
How current understanding of clearance mechanisms and pharmacodynamics of therapeutic proteins can be applied for evaluation of their drug-drug interaction potentialEugenia Kraynov, Steven W Martin, Susan Hurst, et al.
The AAPS Journal|June 2, 2011
AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical developmentSandhya Girish, Steven W Martin, Mark C Peterson, et al.
Cancer|January 28, 2003
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastasesJean-Jacques Body, Philip Greipp, Robert E Coleman, et al.
Inflammatory Bowel Diseases|August 24, 2021
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II StudyGeert R D'Haens, Walter Reinisch, Scott D Lee, et al.
Journal of Crohn'S & Colitis|September 30, 2017
Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn's DiseaseMina Hassan-Zahraee, Anindita Banerjee, John B Cheng, et al.
Journal of Medicinal Chemistry|March 25, 2010
Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humansMark I Lansdell, David Hepworth, Andrew Calabrese, et al.
Pageof 3